Coronavirus Disease 2019 (COVID-19) in Children - What We Know So Far and What We Do Not

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

(2020) Manli Wang et al.   CELL RESEARCH

SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics

(2020) Qing Cao et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

(2020) Peter Richardson et al.   LANCET

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

(2020) Clark D Russell et al.   LANCET

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

(2020) Wenhua Liang et al.   LANCET ONCOLOGY

COVID-19: consider cytokine storm syndromes and immunosuppression

(2020) Puja Mehta et al.   LANCET

BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design

(2019) Camila Covián et al.   Frontiers in Immunology

Virus–virus interactions impact the population dynamics of influenza and the common cold

(2019) Sema Nickbakhsh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile

(2018) Waleed H. Mahallawi et al.   CYTOKINE